Pharmaceuticals Sector - Solvay

Key fi gures [EUR million]
Plastics Sector
2003 2004 [1] 2005 [1]
Sales 3 215 3 093 3 507
REBIT 225 373 389
Depreciation 176 168 174
Capital expenditures 187 165 293
R&D 72 70 79
Headcount [2] 11 262 8 702 8 474
[1] The Industrial Foils activities are included in “discontinued operations” in 2004 and 2005
[2] Full-time equivalents at January 1 of the following year
Sales
breakdown 2005:
EUR 3 507 million
Sales by customer
segment 2005:
EUR 3 507 million
By cluster and SBU
g Specialties
40 %
21 % Specialty Polymers
19 % Inergy Automotive Systems
g Vinyls cluster
60 %
38 % Vinyls
10 % Performance compounds
12 % Pipelife (pipes and fi ttings)
By geographic area
g Europe
53 % European Union (25)
3 % Other European countries
g Asia-Pacifi c
g The Americas
21 % Nafta
12 % Mercosur
g Rest of the world
By customer segment
Automobile industry 29 %
Construction and architecture 24 %
Chemical industry 10 %
Electricity and electronics 9 %
Packaging 8 %
Water and environment 7 %
Consumer goods 6 %
Human health 2 %
Other industries 5 %
10 %
33 %
7 %
8 %
9 %
12 %
38 %
9 %
2 %
6 %
10 %
2%
5 %
21 %
19 %
29 %
24 %
56 %
Jacques van Rijckevorsel
Specialties
(the Specialty Polymers SBU and
the Inergy Automotive Systems
SBU, a 50/50 joint venture with
Plastic Omnium in fuel systems).
2005 was a decisive year for the
growth of
Specialty Polymers.
Major strategic decisions were
taken that will strengthen Solvay’s
global leadership in very-highperformance
polymers markets,
with an emphasis on penetration
in Asia and strongly increasing the
value of its product portfolio.
In China, the foundations for growth
on the domestic market have been
laid with the creation of a Technical
Centre at Shanghai, and the
establishing of a strong commercial
team. Feasibility studies for future
investments in this country have
also progressed well.
33
Solvay Global Annual Report 2005
Plastics